Fig. 3.
Download original image
Fig. 3.
Gamma passing rate with the 2%/2-mm criterion as a function of dose rates for lung, prostate, and head and neck (H&N) disease sites (**P<0.01 and ***P<0.001).
Progress in Medical Physics 2021;32:116-21
https://doi.org/10.14316/pmp.2021.32.4.116
© 2021 Progress in Medical Physics